Boosh Acquires Beanfields
Vancouver, British Columbia--(Newsfile Corp. - February 11, 2022) - Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77i) ("Boosh" or...
Day: February 11, 2022
Canadian School Counselling Week 2022: Who We Are and How We Help
Ottawa, Ontario--(Newsfile Corp. - February 11, 2022) - As students across Canada return to in-person schooling during another school year...
NLS Pharmaceutics to Participate in 2022 BIO CEO & Investor Conference
ZURICH, SWITZERLAND / ACCESSWIRE / February 11, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
After Three Years of Record Growth, Beam Continues Expansion with First Chief Product Officer
Fintech and digital health veteran brings two decades of experience building and scaling digital products.COLUMBUS, Ohio, Feb. 11, 2022 (GLOBE...
NFL LEGEND BRETT FAVRE AND ODYSSEY HEALTH, INC. INVOLVED WITH HUMAN TRIALS OF FIRST DRUG TREATMENT FOR CONCUSSION
NFL LEGEND BRETT FAVRE INVOLVED WITH HUMAN TRIALS OF FIRST DRUG TREATMENT FOR CONCUSSION NFL LEGEND BRETT FAVRE NFL LEGEND...
Adial Pharmaceuticals Announces Pricing of $10 Million Registered Direct Offering
CHARLOTTESVILLE, Va., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage...
Y-mAbs Announces Completion of Pre-BLA Meeting with FDA for Omburtamab
NEW YORK, Feb. 11, 2022 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical...
Amolyt Pharma to Participate at Three Upcoming Investor Conferences
LYON, France and CAMBRIDGE, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic...
Coherus BioSciences to Report Fourth Quarter and Full Year 2021 Financial Results on February 17th, 2022
REDWOOD CITY, Calif., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its fourth quarter...
Metacrine Updates IBD Clinical Development Strategy and Implements Restructuring Plan
U.S. FDA clears IND to evaluate MET642 for the treatment of ulcerative colitisSufficient capital to complete Phase 2 IBD trial...
NRx Reports Remarks by Israel Institute for Biological Research on the future of the BriLife™ Covid-19 Investigational Vaccine
Remarks by Dr. Shmuel Yitzhaki, as published in Globes, an Israeli business newspaperBriLife vaccine may have better neurtralizing ability against...
VIVO Cannabis(TM) Adds Assuage Suppositories to Online Medical Marketplace
Toronto, Ontario--(Newsfile Corp. - February 11, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a...
BTIG to Host Virtual Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference on February 15-17, 2022
Firm Event to Attract More than 125 Industry-Leading and Emerging Healthcare Companies NEW YORK--(BUSINESS WIRE)--BTIG announced today the “BTIG Snowbird...
Senseonics Announces FDA Approval of the Eversense® E3 Continuous Glucose Monitoring System for Use for Up to 6 months; Provides 2022 Business Outlook
The world’s first and only long-term implantable CGM system now offers patients exceptional accuracy for 6 months GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics...
NeoGenomics Liquid Biopsy Subsidiary Inivata and Collaborators Publish Positive Results from Prospective Clinical Study of RaDaR(TM) in Head and Neck Squamous Cell Carcinoma
RaDaR demonstrated 100% specificity in patients with no recurrence and 100% sensitivity in patients with clinical recurrenceFT MYERS, FL /...